Navigation Links
BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
Date:8/29/2012

LYNBROOK, N.Y., Aug. 29, 2012 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia, today announced that Thomas L. Wegman, President of BioSpecifics, will present at the Stifel Nicolaus Weisel Healthcare Conferences 2012 at 9:45 am EDT on Wednesday, September 5, 2012 in Boston, MA.

The live webcast of this presentation may be accessed under "Calendar of Events" in the Investor Relations section of BioSpecifics' website at www.biospecifics.com or at the link http://www.veracast.com/webcasts/stifel/healthcare2012/99104308.cfm. A replay of the webcast will also be available on the Company's website following the presentation.

About BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase (XIAFLEX®) for twelve clinical indications. Currently, XIAFLEX is marketed in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord by Auxilium Pharmaceuticals, Inc. (Auxilium) and is also in clinical development for the treatment of several additional promising indications. Auxilium has reported positive top-line results from two recently completed Phase III clinical trials for Peyronie's disease and is also testing XIAFLEX for frozen shoulder syndrome (adhesive capsulitis) and cellulite in Phase IIa and Phase Ib clinical trials, respectively. BioSpecifics is currently managing the clinical development of XIAFLEX for the treatment of human lipoma and canine lipoma, which are both in Phase II clinical trials.  Auxilium has entered into three strategic partnerships for development and commercialization outside the U.S. of injectable collagenase for Dupuytren's contracture and Peyronie's disease. Pfizer Inc. has rights in Europe and Eurasia and injectable collagenase is currently marketed as XIAPEX® for Dupuytren's contracture in select European countries. Asahi Kasei Pharma Corporation has rights in Japan and Actelion Pharmaceuticals Canada Inc. has rights in Canada, Australia, Brazil and Mexico. For more information, please visit www.biospecifics.com.

 


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
2. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
3. Antifungal Drugs: Technologies and Global Markets
4. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
5. Breast Cancer Diagnostic and Drug Technologies: Global Markets
6. ARAMARK Healthcare Technologies Taps Robert Steele to Lead ReMedPar
7. Montmed to Participate in 2013 Advanced Technologies and Treatments for Diabetes Conference
8. U.S. Navy Awards Multi-Million Dollar Contract to Innovation for Pharmacy Automation Technologies
9. Technologies Impacting the Future of Healthcare
10. ECRI Institute Helps Hospitals Design Spaces for Current and Future Technologies
11. Patient Safety Technologies Reports Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J Face Masks announced ... an aerosol and engineering lab, conducted tests on Q&J’s personal face mask that ... than many other masks. Q&J face masks have both mechanical filtering and electrostatic ...
(Date:9/2/2020)... ... September 02, 2020 , ... ... Covid-19 , Advanced Penetration Technology, LLC, (APT) a Texas- and Indiana-based company ... non-prescription, Over The Counter (OTC) products, was today provided results of an ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... appointed to serve as Secretary to the Board of Trustees and committee chair ... High United Way is a Denver-based nonprofit organization that fights for the education, ...
Breaking Medicine Technology:
(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... of Approval for Sunrise Technologies WALI wireless parking lot controller. This advanced LED ... minimizing glare, reducing light trespass, and protecting the night sky against light pollution. ...
(Date:9/1/2020)... ... 2020 , ... KitoTech Medical, a Seattle-based medical device company, ... be used to accelerate the commercialization of its microMend® family of wound closure ... to expand its customer base of healthcare systems as well as independent hospitals ...
(Date:9/1/2020)... , ... September 01, 2020 , ... ... with specialty fellowship training in aesthetic surgery of the face, breast, and body. ... the only female-owned premier boutique plastic surgery and aesthetic practice in Southwest Florida. ...
(Date:8/31/2020)... ... ... Just found out your dear friend has cancer? , It’s hard to hear your doctor ... their diagnosis. Once the shock wears off, the questions and fears can be overwhelming. , ... ways to help? Words are failing me. I’m scared. I want to DO something. , ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... cloud-based business management solution for chiropractors, announced today the launch of its integrated, ... professionals can start running their virtual practice in under 90 seconds. , ...
Breaking Medicine News(10 mins):